[1]
A. K. Toppo, D. Toppo, D. R. Minj, and R. Gupta, “Association of fibroblast growth factor-23 among chronic kidney disease patients with mineral bone disease”, Int J Adv Med, vol. 8, no. 9, pp. 1372–1377, Aug. 2021.